+987.9%
MRNA vs VRSN
+31.7%
+956.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VRSN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +1.3% | +11.8% | +13.5% |
| 7D | +20.6% | +3.6% | +17.1% | +21.8% |
| 30D | +27.1% | +8.8% | +18.3% | +30.3% |
| 3M | +353.4% | +6.6% | +346.8% | +375.7% |
| 6M | +446.3% | +16.7% | +429.6% | +471.4% |
| YTD | +776.2% | +32.1% | +744.0% | +799.8% |
| 1Y | +987.9% | +34.1% | +953.9% | +1,023.2% |
| All | +987.9% | +31.7% | +956.2% | +1,023.2% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSN.
Daily Out/Under-Performance
Portfolio return minus VRSN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VRSN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling